| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
97.83(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$365.83 - $556.89 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 10 |
| Guru Rank Value : 25.7 |
| Guru Occurances : 5 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
4,588 |
8,535 |
51,010 |
103,437 |
| Total Sell Value |
$1,949,074 |
$3,521,612 |
$24,314,986 |
$51,090,652 |
| Total People Sold |
1 |
3 |
6 |
9 |
| Total Sell Transactions |
1 |
3 |
7 |
17 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2024-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,710 |
9,287 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2024-11-01 |
4 |
D |
$414.01 |
$350,252 |
D/D |
(846) |
7,577 |
|
- |
|
| Haytaian Peter D |
EVP & Pres Carelon & CarelonRx |
• – – |
2024-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,799 |
21,037 |
|
- |
|
| Haytaian Peter D |
EVP & Pres Carelon & CarelonRx |
• – – |
2024-11-01 |
4 |
D |
$414.01 |
$682,702 |
D/D |
(1,649) |
17,238 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2024-10-18 |
4 |
S |
$432.14 |
$3,205,182 |
D/D |
(7,417) |
8,423 |
|
8% |
|
| Kaye Mark |
EVP & CFO |
• – – |
2024-10-02 |
4 |
D |
$505.16 |
$1,423,541 |
D/D |
(2,818) |
20,213 |
|
- |
|
| Peru Ramiro G |
Director |
– • – |
2024-08-05 |
4 |
AS |
$531.52 |
$400,235 |
D/D |
(753) |
8,744 |
|
-28% |
|
| Boudreaux Gail |
President and CEO |
• • – |
2024-07-22 |
4 |
AS |
$498.50 |
$17,033,395 |
D/D |
(34,000) |
126,709 |
|
-20% |
|
| Dixon Robert L Jr |
Director |
– • – |
2024-07-19 |
4 |
S |
$506.76 |
$154,562 |
D/D |
(305) |
9,721 |
|
20% |
|
| Peru Ramiro G |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
9,497 |
|
- |
|
| Neri Antonio F |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
4,324 |
|
- |
|
| Clark R Kerry |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
9,039 |
|
- |
|
| Dixon Robert L Jr |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
10,026 |
|
- |
|
| Devore Susan D. |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
1,701 |
|
- |
|
| Schneider Ryan M. |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
5,999 |
|
- |
|
| Hay Lewis III |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
10,906 |
|
- |
|
| Tallett Elizebeth E |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
10,291 |
|
- |
|
| Strable-Soethout Deanna D |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
1,045 |
|
- |
|
| Jallal Bahija |
Director |
– • – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
4,187 |
|
- |
|
| Norwood Felicia F |
EVP & President,Gov Health Ben |
• – – |
2024-04-24 |
4 |
S |
$532.14 |
$3,300,590 |
D/D |
(6,199) |
27,304 |
|
-3% |
|
| Norwood Felicia F |
EVP & President,Gov Health Ben |
• – – |
2024-04-24 |
4 |
OE |
$238.27 |
$486,786 |
D/D |
2,043 |
33,503 |
|
- |
|
| Norwood Felicia F |
EVP & President,Gov Health Ben |
• – – |
2024-04-23 |
4 |
S |
$533.73 |
$7,531,565 |
D/D |
(14,111) |
31,460 |
|
-5% |
|
| Norwood Felicia F |
EVP & President,Gov Health Ben |
• – – |
2024-04-23 |
4 |
OE |
$238.27 |
$1,304,052 |
D/D |
5,473 |
45,571 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2024-03-08 |
4 |
S |
$500.46 |
$1,217,119 |
D/D |
(2,432) |
15,840 |
|
1% |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2024-03-06 |
4 |
S |
$504.58 |
$462,195 |
D/D |
(916) |
1,764 |
|
-3% |
|
88 Records found
|
|
Page 1 of 4 |
|
|
7.47 (1.96%) 
